The ranking Republican on the Senate Finance Committee wants Eli Lilly to produce documents for the panel regarding accusations it played down risks of Zyprexa. Several lawsuits against the company claim the drugmaker wrongly promoted Zyprexa, for treating schizophrenia and bipolar disorder, and played down its risks. Sen. Charles Grassley, R-Iowa, wants information similar to that already requested by a House committee.

Full Story:

Related Summaries